Bainbridge Island, WA, United States of America

Antonio Campos-Neto

This inventor holds 31 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Immunotherapy Research. Top assignee: Corixa Corporation. Active years: 1998-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonio Campos-Neto. Retrieved from https://idiyas.com/inventor/antonio-campos-neto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 (Patent Applications = 4)

% Patents Active = 54.8

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 5.9

ph-index = 15

Forward Citations = 490(Granted Patents)

Location History:

King, WA (US) (1998)
Bainbridge Island, WA (US) (2001 - 2011)

Company Filing History:

31 out of 247

Corixa Corporation

patents

Years Active: 1998-2011

Loading Chart...

Areas of Expertise:

Immunotherapy

Diagnosis

Tuberculosis

Leishmaniasis

Fusion Proteins

Mycobacterium

Antigens

Compounds

Therapy

Methods

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8084042 - Compounds and methods for immunotherapy and diagnosis of tuberculosis (2011-12-27),

2. 7989605 - Compounds and methods for immunotherapy and diagnosis of tuberculosis (2011-08-02),

3. 7935353 - Compounds and methods for diagnosis and immunotherapy of tuberculosis (2011-05-03),

4. 7927611 - Compounds and methods for diagnosis and immunotherapy of tuberculosis (2011-04-19),

5. 7927610 - Compounds and methods for diagnosis and immunotherapy of tuberculosis (2011-04-19),

6. 7927609 - Compounds and methods for immunotherapy and diagnosis of tuberculosis (2011-04-19),

7. 7906277 - Compound and methods for diagnosis of tuberculosis (2011-03-15),

8. 7335369 - [object Object] (2008-02-26),

9. 7238358 - Compounds and methods for immunotherapy and diagnosis of tuberculosis (2007-07-03),

10. 7122196 - Compounds and methods for diagnosis of tuberculosis (2006-10-17),

11. 7087713 - Compounds and methods for diagnosis and immunotherapy of tuberculosis (2006-08-08),

12. 7064195 - Fusion proteins of mycobacterium tuberculosis antigens and their uses (2006-06-20),

13. 6977069 - Fusion proteins of Mycobacterium tuberculosis antigens and their uses (2005-12-20),

14. 6962710 - Compounds and methods for immunotherapy and diagnosis of tuberculosis (2005-11-08),

15. 6949246 - Compounds and methods for diagnosis of tuberculosis (2005-09-27),

Title: Innovator Spotlight: Antonio Campos-Neto, Pioneering Immunotherapy Inventor

Introduction:

Antonio Campos-Neto, a prolific inventor based on Bainbridge Island, WA, has made significant contributions to the field of immunotherapy. With an impressive portfolio of 31 patents, Campos-Neto's work focuses on developing compounds and methods for inducing protective immunity against tuberculosis.

Latest Patents:

One of Campos-Neto's groundbreaking patents is the "Compounds and methods for immunotherapy and diagnosis of tuberculosis," where he discloses innovative polypeptides and DNA molecules for immunization and diagnosis of tuberculosis. These compounds play a crucial role in developing vaccines and pharmaceutical compositions for combating tuberculosis infections.

Career Highlights:

Campos-Neto's expertise shines through his tenure at Corixa Corporation, a company renowned for its advancements in immunotherapy. His dedication to researching and developing novel solutions for infectious diseases has led to the successful patenting of numerous cutting-edge technologies.

Collaborations:

In his pursuit of excellence, Campos-Neto has collaborated with esteemed colleagues such as Davin C Dillon and Steven G Reed. Together, they have worked on various projects aimed at revolutionizing the field of immunotherapy and establishing new standards in the fight against infectious diseases.

Conclusion:

Antonio Campos-Neto's remarkable journey as an inventor and innovator in the realm of immunotherapy serves as a testament to his unwavering commitment to advancing medical science. His patents and collaborations underscore his significant impact on the industry, shaping the landscape of healthcare for the better.

Profile summary based on public USPTO records.